Loop gain is an engineering concept borrowed from control theory that describes how aggressively your body’s breathing control system responds to changes in ventilation. In simple terms, it’s the ratio of your body’s corrective response to the size of the disturbance that triggered it. A loop gain of 0.5 means your system responds with half the force of the original disturbance, gently steering breathing back to normal. A loop gain above 1.0 means your system overcorrects, creating a cycle of unstable breathing that can spiral into repeated apneas during sleep.
The concept matters most in the context of sleep apnea. Unstable ventilatory control, quantified as loop gain, is now recognized as one of four key traits that contribute to obstructive sleep apnea. Understanding it helps explain why some people with narrowed airways develop severe apnea while others with similar anatomy do not.
How the Breathing Feedback Loop Works
Your body regulates breathing through a negative feedback loop, much like a thermostat regulates temperature. When something disrupts your breathing (a partially blocked airway, for example), carbon dioxide builds up in your blood. Sensors called chemoreceptors detect that rise and signal your brain to increase breathing effort. The stronger breathing clears the excess CO2, and the system settles back down. That’s the loop.
Loop gain is the ratio of the corrective ventilatory response to the original disturbance. If your airway partially collapses and your ventilation drops by a certain amount, loop gain tells you how large the rebound breathing effort will be relative to that drop. When the system is well-tuned, the correction is proportional and breathing stabilizes quickly. When loop gain is too high, the correction overshoots. Your brain drives a burst of breathing that blows off too much CO2, which then causes breathing to slow or stop entirely, which lets CO2 rise again, triggering another exaggerated response. This creates the waxing-and-waning (crescendo-decrescendo) breathing pattern visible on sleep studies.
The Three Components of Loop Gain
Loop gain is the product of three separate gains working in sequence: controller gain, plant gain, and feedback gain.
Controller gain reflects how sensitive your brain’s chemoreceptors are to changes in CO2. Two sets of sensors matter here: peripheral chemoreceptors in the carotid bodies (located in the neck near the carotid arteries) and central chemoreceptors in the brainstem. These don’t simply add their signals together. Research in animal models has shown the relationship is “hyperadditive,” meaning the carotid body sensors actively amplify the sensitivity of the central sensors. When carotid body input was inhibited, the central CO2 response dropped to just 19% of its normal value. When carotid body input was stimulated, the central response jumped to 223% of normal. This interdependence means even modest changes in peripheral chemoreceptor sensitivity can dramatically shift your overall controller gain.
Plant gain describes how efficiently a change in breathing actually changes CO2 levels in your blood. “Plant” refers to the lungs and body tissues. Someone with smaller lungs or lower baseline ventilation will see a larger CO2 swing for the same change in airflow, meaning their plant gain is higher. This is one reason loop gain tends to be elevated during sleep, when breathing naturally becomes shallower and lung volumes decrease.
Feedback gain accounts for the delay and dilution that occur as blood travels from the lungs to the chemoreceptors. CO2-rich blood leaving the alveoli mixes with blood already in circulation and takes time to reach the sensors. This circulatory delay is a destabilizing factor: the longer the delay, the more likely the system is to overcorrect because it’s always responding to outdated information. People with heart failure, for instance, have slower circulation and longer delays, which partly explains their high rates of central sleep apnea.
Why the Threshold of 1.0 Matters
The critical number in loop gain is 1.0. Below that threshold, the system is self-correcting. Each response is smaller than the disturbance that caused it, so oscillations dampen and breathing stabilizes. Above 1.0, each response is larger than the preceding disturbance. Oscillations grow rather than shrink, producing the cyclical pattern of hyperventilation and apnea known as periodic breathing.
In practice, you don’t need a loop gain above 1.0 to run into trouble. A loop gain around 0.5, while not enough to cause frank instability on its own, can be a significant contributor to sleep-disordered breathing when combined with a collapsible airway. The system doesn’t produce self-sustaining oscillations at that level, but it does overcorrect enough to destabilize the upper airway muscles, triggering obstructive events. Reducing that value to around 0.20 with treatment can meaningfully decrease the number of disordered breathing events per hour.
How Loop Gain Is Measured
Measuring loop gain in a clinical setting typically happens during a sleep study. One approach uses brief drops in CPAP pressure while a patient sleeps. By reducing the pressure momentarily, clinicians create a controlled disturbance to ventilation and then measure how aggressively the breathing system responds. The size of the ventilatory rebound relative to the size of the induced disturbance gives the loop gain value.
On a standard polysomnogram, high loop gain often shows up as a characteristic waxing-and-waning breathing pattern: breaths gradually grow larger, peak, then gradually shrink before another apnea occurs. This crescendo-decrescendo signature is a visual hallmark of an unstable ventilatory control system. When clinicians see this pattern, particularly in patients whose central apneas persist on CPAP, high loop gain is a likely culprit. Research on complex sleep apnea patients found that those who failed to respond to CPAP had baseline loop gain values roughly 40% further above the critical threshold of 1.0 compared to responders.
Treatments That Lower Loop Gain
Supplemental Oxygen
Breathing supplemental oxygen during sleep reduces loop gain primarily by dampening peripheral chemoreceptor sensitivity, which lowers controller gain. The effect is most dramatic in people who start with high loop gain. In one study, patients with unstable ventilatory control saw their loop gain drop from 0.69 to 0.34 with oxygen, and their number of breathing disruptions per hour fell by 53%. Patients who already had low loop gain saw little benefit, which highlights an important point: oxygen therapy for sleep apnea works best when the underlying problem is ventilatory instability rather than pure anatomical obstruction.
Acetazolamide
Acetazolamide, a medication that makes blood slightly more acidic by changing how the kidneys handle bicarbonate, reduces loop gain by about 41% in people with obstructive sleep apnea. Interestingly, this reduction is driven almost entirely by lowering plant gain rather than controller gain. The drug shifts the body’s CO2 setpoint so that the same change in breathing produces a smaller swing in blood CO2 levels. Controller gain (chemoreceptor sensitivity) stays unchanged. This distinction matters because it means the two main therapeutic approaches, oxygen and acetazolamide, target different components of the same feedback loop and could theoretically complement each other.
CPAP
Continuous positive airway pressure is primarily prescribed to splint the airway open, but it also reduces loop gain over time. Studies in OSA patients show that the ventilatory response to CO2 stimulation (which incorporates both controller and plant gain) decreases following CPAP treatment. By eliminating the repeated oxygen drops and CO2 surges that occur with untreated apnea, CPAP may gradually recalibrate the chemoreceptors to be less reactive.
Who Has High Loop Gain
Several factors push loop gain higher. Heart failure increases circulatory delay time, giving the feedback loop stale information and promoting oscillation. Sleeping at high altitude, where lower oxygen levels rev up chemoreceptor sensitivity, raises controller gain. Chronic untreated sleep apnea itself can elevate loop gain by sensitizing the chemoreceptors through repeated episodes of low oxygen, creating a self-reinforcing cycle.
Men tend to have slightly higher loop gain than women, which may partly explain the higher prevalence of sleep apnea in men. People with naturally heightened CO2 sensitivity, sometimes described as having a “brisk” ventilatory response, also tend toward higher loop gain. This trait has a genetic component and varies widely between individuals, which is one reason two people with identical airway anatomy can have very different apnea severity.
Loop gain is not the whole story in sleep apnea. It is one of four key traits alongside airway collapsibility, the arousal threshold (how easily you wake up), and the responsiveness of the muscles that hold the airway open. But for the subset of patients whose apnea is driven largely by ventilatory instability, identifying and targeting high loop gain can be the difference between treatment success and failure.